Self-monitoring of blood glucose: Advanced technologies and treatments for diabetes

International Journal of Clinical Practice

Volumn 64, Issue SUPPL. 166, 2010, Pages 1-10

  Garg, S ^a   Hirsch, I B ^b  

^a UNIVERSITY OF COLORADO DENVER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLITAZONE DERIVATIVE; GLUCOSE; GLUCOSE DEHYDROGENASE; HEMOGLOBIN A1C; INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; PYRROLOQUINOLINEQUINONE; SULFONYLUREA;

BLOOD GLUCOSE MONITORING; BLOOD SAMPLING; CARDIOVASCULAR RISK; CLINICAL TRIAL; DIABETES CONTROL; DIAGNOSTIC ACCURACY; DIET THERAPY; DISEASE DURATION; ETHNIC GROUP; FEEDING BEHAVIOR; FINGER; FOREARM; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEALTH CARE COST; HEART INFARCTION; HEMOGLOBIN BLOOD LEVEL; HISPANIC; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN TREATMENT; LOWEST INCOME GROUP; MEDICAL SPECIALIST; MICROANGIOPATHY; NEGRO; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; OUTCOME ASSESSMENT; PHYSICIAN; PREGNANCY DIABETES MELLITUS; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REIMBURSEMENT; RISK ASSESSMENT; SELF MONITORING; STROKE; UNITED STATES;

EID: 76749098491     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2009.02271.x     Document Type: Note

References (20)

1. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependant diabetes mellitus. N Engl J Med 1993 329 : 977 986.
2. Nathan DM. Long-term complications of diabetes mellitus. N Engl J Med 1993 328 : 1676 1685.
3. Diabetes Control and Complications Trial Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005 353 : 2643 2653.
4. Turner RC, Cull CA, Frighi V, Holman RR, for the UK Prospective Diabetes Study Group. Glycaemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus. J Am Med Assoc 1998 281 : 2005 2012.
5. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998 352 : 837 853.
6. Gray A, Raikou M, McGuire A et al on behalf of the UK Prospective Diabetes Study Group Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomized controlled trial (UKPDS 41). Br Med J 2000 320 : 1373 1378.
7. Diabetes Control and Complications Trial Research Group. Resource utilization and costs of care in the diabetes control and complications trial. Diabetes Care 1995 18 : 1468 1478.
8. The Action to Control Cardiovascular Riskin Diabetes Study Group (ACCORD). Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008 358 : 2545 2559.
9. The ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcome in patients with type 2 diabetes. N Engl J Med 2008 358 : 2560 2572.
10. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, Zieve FJ, Marks J, Davis SN, Hayward R, Warren SR, Goldman S, McCarren M, Vitek ME, Henderson WG, Huang GD. for the VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009 360 : 1 11.
11. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2005. Atlanta, GA : US Department of Health and Human Services, Centers for Disease Control and Prevention, 2005.
12. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2003, Revised edn. Atlanta, GA : US Department of Health and Human Services, Centers for Disease Control and Prevention, 2004.
13. Diabetes Epidemiology Research International Group. Secular trends in incidence of childhood IDDM in 10 countries. Diabetes 1990 39 : 858 864.
14. Onkamo P, Vaananen S, Karvonen M, Tuomilehto J. Worldwide increase in incidence of type 1 diabetes - the analysis of the data on published incidence trends. Diabetologia 1999 42 : 1395 1403.
15. Vehik K, Hamman FR, Lezotte D et al. Increasing incidence of type 1 diabetes mellitus in 0 to 17-year-old Colorado youth. Diabetes Care 2007 30 : 503 509.
16. Rizza R, Vigersky R, Rodbard H et al. A model to determine workforce needs for endocrinologists in the United States until 2020. Diabetes Care 2003 26 : 1545 1552. (Pubitemid 36929194)
17. Garg SK, Schwartz S, Edelman SV. Improved glucose excursions using an implantable real-time continuous implanted glucose sensor in adults with type 1 diabetes. Diabetes Care 2004 27 : 734 738.
18. Garg SK, Zisser H, Schwartz S et al. Improvement in glycaemic control with a transcutaneous, real-time continuous glucose sensor: randomized controlled trial. Diabetes Care 2006 29 : 44 50.
19. Garg S, Jovanovic L. Clinical trial of a seven-day continuous glucose sensor demonstrates the importance of fasting hyperglycemia and the dawn phenomenon. Diabetes Care 2007 29 : 2644 2649.
20. Bailey TS, Zisser H, Garg SK. Reduction in hemoglobin A1c with real-time continuous glucose monitoring: results from a 12-week study. Diabetes Technol Ther 2007 9 : 203 210.